TipRanks
Blue Owl Capital (OBDC)
NYSE:OBDC
US Market
Want to see OBDC full AI Analyst Report?
EarningsQ2 2026 Earnings Report

Blue Owl Capital (OBDC) Q2 2026 Earnings Report

1,857 Followers

OBDC Q2 2026 EPS Results

Actual EPS$0.34
Consensus EPS$0.32
Beat/MissBeat by +$0.02
One Year Ago EPS$0.42

OBDC Q2 2026 Revenue Results

Actual Revenue$387.26M
Expected Revenue$394.23M
Beat/MissMissed by -$6.97M
YoY Revenue Growth-23.57%

Earnings Announcement Details

QuarterQ2 2026
Date08/05/2026
TimeAfter Close
Conference CallWednesday, August 5, 2026
OBDC Upcoming Earnings
Blue Owl Capital's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

OBDC Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
Overall the call communicated a largely positive operational and financial update: NII and ROE improved, dividend coverage was healthy with a supplemental payout, leverage was reduced to the lowest level in over two years, liquidity and funding structure were strengthened, and the portfolio continued to show stable credit metrics and diversified, defensive exposures. The primary negatives were a modest NAV decline driven by a single-name markdown (Loparex), muted new-deal activity and refinancing in the market, some reliance on one-time realizations for elevated income, and modestly higher funding costs — but these negatives were isolated and outweighed by the quarter's constructive developments.
Company Guidance
Management reiterated a Q3 base dividend of $0.31 (paid Oct. 15; record Sept. 30) plus a $0.02 supplemental (paid Sept. 15; record Aug. 31), supported by Q2 adjusted NII of $0.34 (up from $0.31 prior quarter) which translated to a 9.6% annualized ROE (up >100 bps) and quarterly base dividend coverage of ~110%, with spillover income of roughly $0.29/share; NAV was $14.26 (down from $14.41), aided by $35M of share repurchases in Q2 (about $220M since Q4) that were accretive ~ $0.03 to NAV. Balance sheet guidance emphasized flexibility: net leverage ended 1.11x (target range 0.9–1.25x; lowest in >2 years), fundings of $429M vs $747M of repayments, total liquidity ~$3.5B (including a $4B revolver), ~$800M of unsecured debt raised to cover ~ $1B of maturities, and elimination of two secured facilities. Credit and portfolio metrics reinforced confidence: non‑accruals 0.8% at fair value (platform 1% of cost), platform loss rate since inception 12 bps, PIK as % of investment income ~10.7% (down from >13%), portfolio revenue/EBITDA growth mid‑to‑high single digits, avg position ~40 bps, software 18% of portfolio, interest coverage ~2x, avg company net leverage 5.8x, LTVs ~47%, and management noted the forward rate curve is roughly 100 bps higher and spreads/terms are more attractive—supporting a patient, selective deployment posture as the opportunity set improves.
Adjusted NII and ROE Improvement
Adjusted net investment income (NII) was $0.34 per share in Q2, up from $0.31 in Q1 (~+9.7%), translating into a 9.6% annualized ROE — up over 100 basis points quarter-over-quarter and providing a healthy cushion above the base dividend.
Dividend Coverage and Supplemental Dividend
Base dividend coverage was ~110% this quarter; the board declared a Q3 base dividend of $0.31 per share and a $0.02 per share supplemental dividend. Spillover income remained ~ $0.29 per share, supporting dividend sustainability.
Large Realization: Mavis Tire Repayment
Repaid preferred equity in Mavis Tire generated ~ $274 million in cash (including $66 million of accrued PIK) and produced a 1.5x MOIC. This was the largest PIK realization to date and drove elevated fee income (~$0.03 per share).
PIK Exposure Decline
PIK as a percentage of total investment income declined to 10.7% in Q2, down from peak levels of over 13% two years ago, reflecting realized exits and portfolio evolution.
Strengthened Balance Sheet and Liquidity
Net leverage decreased to 1.11x (lowest in >2 years) after $429 million of fundings vs $747 million of repayments. Total liquidity post-July actions remained robust at approximately $3.5 billion (cash + undrawn capacity), comfortably exceeding unfunded commitments.
Capital Markets and Funding Actions
Issuer executed financing improvements including issuing ~ $800 million of unsecured debt, extending a $4 billion revolver (all banks extended, pricing unchanged), and eliminating two higher-cost secured facilities — improving the funding profile.
Share Repurchases and NAV Accretion
Repurchased $35 million of stock in Q2 (and ~$220 million since Q4 prior year), which was accretive to NAV by ~$0.03 per share and demonstrates disciplined capital allocation alongside maintaining leverage flexibility.
Portfolio Credit Health and Diversification
Portfolio remains diversified across 30+ industries with average position size ~40 bps. Revenue and EBITDA grew mid- to high-single digits YoY; interest coverage ~2x; portfolio company net leverage averaged 5.8x; LTVs ~47%. Non-accruals at fair value were low at 0.8%.
Strong Specialty Finance Results
Life sciences vehicle LSI delivered notable returns: LSI has generated >15% returns to OBDC since inception and realized a high-return repayment (ITM Radio Pharma) that produced >20% IRR on a $140 million position driving incremental dividend income this quarter.

OBDC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 04, 2026
2026 (Q3)
0.32 / -
0.37―
2026 (Q2)
0.32 / 0.34
0.42-19.05% (-0.08)
2026 (Q1)
0.35 / 0.31
0.41-24.39% (-0.10)
2025 (Q4)
0.35 / 0.38
0.47-19.15% (-0.09)
2025 (Q3)
0.40 / 0.37
0.47-21.28% (-0.10)
2025 (Q2)
0.40 / 0.42
0.48-12.50% (-0.06)
2025 (Q1)
0.43 / 0.41
0.47-12.77% (-0.06)
2024 (Q4)
0.45 / 0.47
0.51-7.84% (-0.04)
2024 (Q3)
0.48 / 0.47
0.49-4.08% (-0.02)
2024 (Q2)
0.47 / 0.48
0.480.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed